SCHEMBL6027074

SCHEMBL6027074

O=Cc1c(O)cccc1OCCCCC(=O)OCc1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 1/20 0.43
ADRA1D P25100 1/20 0.43
ADRA1A P35348 1/20 0.43
ADRA1B P35368 1/20 0.43
L3MBTL1 Q9Y468 2/20 0.41
ALDH1A1 P00352 1/20 0.41
MAPK1 P28482 1/20 0.41
TDP1 Q9NUW8 2/20 0.41
MAPT P10636 2/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
LMNA P02545 2/20 0.39
LTA4H P09960 1/20 0.39
PTGER1 P34995 1/20 0.39
PTGER4 P35408 1/20 0.39
PTGER3 P43115 1/20 0.39
PTGER2 P43116 1/20 0.39
DRD2 P14416 1/20 0.39
DRD4 P21917 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6027006 0.84 LTA4H (0.44) LTA4H
SCHEMBL10926348 0.83 CNR1 (0.43) ALDH1A1TDP1LTA4H
SCHEMBL10918453 0.82 LTA4H (0.51) HTR1AADRA1DADRA1AADRA1BL3MBTL1
Velaresol SCHEMBL61907 0.82 PPARA (0.44) ALDH1A1MAPTSMN1; SMN2LMNAJAK2
SCHEMBL6026140 0.81 LTB4R (0.45) ALDH1A1MAPTSMN1; SMN2LMNAJAK2
SCHEMBL6027258 0.81 LTB4R (0.45) ALDH1A1MAPTSMN1; SMN2LMNAJAK2
SCHEMBL2370214 0.80 MAPT (0.57) HTR1AADRA1DADRA1AADRA1BL3MBTL1
SCHEMBL6026753 0.79 LMNA (0.42) L3MBTL1ALDH1A1TDP1MAPTSMN1; SMN2
SCHEMBL10920283 0.79 NPC1 (0.50) HTR1AADRA1DADRA1AADRA1BL3MBTL1
SCHEMBL6026502 0.78 TSHR (0.44) ALDH1A1TDP1MAPTSMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7074770-B1 Method of DNA vaccination SMITHKLINE BEECHAM CORPORATION (US) 2006-07-11 US claimed
EP-1107785-A1 METHOD OF DNA VACCINATION GLAXO GROUP LIMITED (GB) 2001-06-20 EP claimed
WO-2000012121-A1 METHOD OF DNA VACCINATION GLAXO GROUP LIMITED (GB) 2000-03-09 WO claimed
US-7074770-B1 Method of DNA vaccination SMITHKLINE BEECHAM CORPORATION (US) 2006-07-11 US disclosed
EP-1107785-A1 METHOD OF DNA VACCINATION GLAXO GROUP LIMITED (GB) 2001-06-20 EP disclosed
WO-2000012121-A1 METHOD OF DNA VACCINATION GLAXO GROUP LIMITED (GB) 2000-03-09 WO disclosed
EP-0614357-A1 IMMUNOPOTENTIATORY AGENTS THE WELLCOME FOUNDATION LIMITED (GB) 1994-09-14 EP disclosed
WO-1994007479-A2 IMMUNOPOTENTIATORY AGENTS THE WELLCOME FOUNDATION LIMITED (GB) 1994-04-14 WO disclosed